Navigation Links
Joseph Glorioso, Ph.D., receives Pioneer Award
Date:2/19/2014

New Rochelle, NY, February 19, 2014Joseph C. Glorioso, III, PhD (University of Pittsburgh School of Medicine, PA) devoted much of his research career to developing herpes viruses as efficient vectors for delivering therapeutic genes into cells. In recognition of his leadership and accomplishments, he has received a Pioneer Award from Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Human Gene Therapy is commemorating its 25th anniversary by bestowing this honor on the leading 12 Pioneers in the field of cell and gene therapy selected by a blue ribbon panel* and publishing a Pioneer Perspective by each of the award recipients. The Perspective by Dr. Glorioso is available on the Human Gene Therapy website.

As he recounts in his essay "Herpes Simplex Viral Vectors: Late Bloomers with Big Potential," it took 30 years to create broadly applicable HSV vector designs and a useful gene delivery platform. Since herpes simplex virus has a natural affinity for the nervous system, Dr. Glorioso believes that "gene delivery to the brain represents the most important frontier for HSV-mediated gene therapy and provides a unique opportunity to study complex processes such as learning and memory and to treat complex genetic and acquired diseases, including brain degeneration, epilepsy, and cancer."

In addition, says Dr. Glorioso, some herpes viral delivery systems are proving useful for gene transfer in the emerging field of cellular reprogramming to produce stem cells for tissue regeneration.

"Joe began his work in gene therapy early in the development of the field focusing on the very challenging objective of targeting the central nervous system. His work with HSV vectors represents an incredibly elegant blending of basic virology and tra
'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100 x2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1 2

Related biology news :

1. The American Society of Hematology honors Andrew S. Weyrich, Ph.D., with 2013 William Dameshek Prize
2. INRS receives 7 NSERC Strategic Project Grants
3. Ronald Crystal, M.D., receives Pioneer Award
4. GW receives up to $14.6 million to develop method to characterize security threats
5. Carnegies Chris Field receives BBVA Climate Change Award
6. Hoyos Labs Receives Envisioneering Innovation & Design Award at the 2014 ShowStoppers at the Consumer Electronics Show
7. Virginia Tech engineer receives NSF grant to study Colorado flood effects on antibiotic resistance
8. Virginia Techs De Vita receives governments highest of engineering honors to study pelvic disorder
9. OU professor receives national fellowship to complete biography on Ancel Keys and the American diet
10. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
11. Clemson professor receives Menzie Environmental Education Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Joseph Glorioso, Ph.D., receives Pioneer Award
(Date:8/12/2015)... August 12, 2015 As the ... payment innovation and advanced biometrics technology is accelerating beyond ... consumers rely on using their credit cards, the digital ... future for payment services led by companies in the ... :  Google, Inc. (NASDAQ: GOOG ), Apple Inc. ...
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015 ... developer of human interface solutions, today announced collaboration ... technologies on Windows 10. Microsoft leveraged Synaptics, deep ... the operating system. Through stringent ... are fully certified with Microsoft,s Precision TouchPad (PTP) ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... York City’s smoking rate has plummeted since a comprehensive ... findings issued today in the national Centers for Disease ... The 2006 rate was nearly 20% lower than the ... smokers. The City’s rate for 2006 is the lowest ...
... of California, San Diego (UCSD) Skaggs School of Pharmacy ... a human vaccine to prevent against Human Cytomegalovirus (hCMV) ... of herpes virus, is the leading viral cause of ... compromised immune systems. The body’s natural immunity doesn’t ...
... are the bad guys that help bacterial pathogens do their ... system. In essence, they knock down the front door ... researchers at the University of California, San Diego (UCSD) School ... effector protein called YpkA, one of several effectors of the ...
Cached Biology News:Smoking rate has plummeted in New York City 2New vaccine prevents CMV infection and disease in mice 2New vaccine prevents CMV infection and disease in mice 3How plague-causing bacteria disarm host defense 2
(Date:9/2/2015)... Research and ... addition of Jain PharmaBiotech,s new report ... to their offering. The scope ... in situ hybridization (FISH), comparative genomic hybridization ... application of nanobiotechnology, microarrays, real-time polymerase chain ...
(Date:9/2/2015)... 2, 2015 Australian prostate cancer technology company ... science prize recognising ,outstanding, science that uses its patented ... launch a novel prostate cancer diagnostic test known as ... consortium taking out the peer-reviewed Australian Museum Eureka Science ... This prize is awarded for ground breaking ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... efficiency of their entire waste to energy process and continue to contribute to ... Major Upgrade , Temarry’s Waste to Energy process has been operating at their ...
Breaking Biology Technology:Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
... July 17 Encorium Group, Inc. (Nasdaq: ... research organization (CRO) that provides design, development, and management ... of the world,s leading pharmaceutical companies, today announced that ... Company,s U.S. business to Pierrel Research USA, Inc., a ...
... 16 Nile Therapeutics, Inc. (Nasdaq: NLTX ), a ... patients, today announced that it has completed a private placement of ... stock for aggregate gross proceeds of approximately $3.4 million. Riverbank Capital ... agent for the transaction. , , ...
... - Introductory Webinar, July 21st, 11am EDT, ... September 15-16, San Diego,CA , ChemAxon, a ... Excel. The add-in for Microsoft Excel(R),brings all of the capabilities and ... will be introduced at a free webinar,on July 21st and Workshop ...
Cached Biology Technology:Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 2Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 3Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 4Nile Therapeutics, Inc. Completes $3.4 Million Private Placement 2Nile Therapeutics, Inc. Completes $3.4 Million Private Placement 3ChemAxon Launches JChem for Excel 2